Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 121 - 140 of 161
  • «
  • ...
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • »
The biosimilar market is heating up. The U.S. Food and Drug Administration (FDA) has approved 23 biosimiliars to date, and they are increasingly being made available to U.S. consumers. In July, Amgen and Allergan launched the first two anticancer biosimilars in the U.S. market. According to their manufacturers, these biologics alternatives—Mvasi®, a bevacizumab biosimilar referencing Avastin®, and …
At the end of last month, the Centers for Medicare & Medicaid Services (CMS) released the much-anticipated calendar year (CY) 2020 Medicare Payment rules. Touted by CMS as an effort to “empower patients with price transparency and increase competition to lower costs for Medicare beneficiaries,” the proposed Outpatient Prospective Payment System (OPPS) rule for 2020 introduces new price transparency …
This is the second part of a report on the ACCC Financial Advocacy Network Learning Lab held on December 5, 2018, at Vanderbilt-Ingram Cancer Center (VICC) in Nashville, Tenn. While part one addressed the barriers VICC identified as preventing its provision of optimal financial advocacy services to all patients, part two describes findings at a three-month follow-up evaluation. Within the three months …
Spoiler Alert: If you missed this week’s ACCC webinar on “A Review of Validated Tools for Geriatric Assessment and How to Use Them,” this blog post starts with the bottom line takeaway. Presenter Tanya M. Wildes, MD, cut to the chase in concluding Monday’s webinar: “Let’s agree to stop saying that it [geriatric assessment] is time-consuming!” Contrary to popular belief, she said, assessments for elderly …
Calling it America’s “other big drug problem,” advanced practice pharmacist Ginah Nightingale, PharmD, BCOP, set the stage for a discussion on a critical issue of concern for geriatric cancer patients: polypharmacy. This third of six webinars presented as part of ACCC's Multidisciplinary Approaches to Caring for Geriatric Patients with Cancer project, delved into how excessive prescribing for older …
Patients with cancer experience a variety of difficulties in accessing and managing their medications. The Legacy Health Cancer Institute established an oncology pharmacy navigator to decrease barriers to patient access, reconcile medication lists, and alleviate the financial burden of cancer care.
Acute lymphoblastic leukemia (ALL) is a fast-moving malignancy of the blood and bone marrow. Although ALL affects both adults and children, it does so very differently. Regardless of a patient’s age, a diagnosis of ALL can be sudden and unexpected. Because patients with ALL often have non-specific symptoms, diagnoses can come as a shock to them and their families, and patients often need to begin …
In the Department of Pharmacy at the University of North Carolina North Carolina Cancer Hospital, discarding partial drug vials was a significant source of waste. With their Innovator Award–winning drug vial optimization program, the program maximized the lifespan of drugs within single-dose vials and realized an annual cost savings of more than $40 million.
As part of a multidisciplinary team education project on acute lymphocytic leukemia (ALL), ACCC recently released an environmental scan that provides an overview of the current landscape for ALL diagnosis and treatment, along with potential opportunities to improve care for this patient population. In this final post in a three-part series, guest blogger Mohammed Hersi, PharmD, BCPS, describes the …
The ACCC Immuno-Oncology Institute developed a multidisciplinary curriculum workshop bringing together faculty experienced in delivery of immunotherapy with cancer program staff in the earlier stages of IO integration. Over the past two years, these IO Visiting Experts Programs were hosted by ACCC Cancer Program Members nation-wide.
Each year, in conjunction with the ACCC Annual Meeting and Cancer Center Business Summit, ACCC members come to Washington, D.C., for our Capitol Hill Day. Across the board, these members tell us how much they’ve enjoyed this unique opportunity to meet in small groups, or even one-on-one, with their legislators and congressional staffers to talk about challenges—and successes—at their cancer programs …
On October 25, 2018, President Trump addressed a campaign promise ahead of the heavily contested mid-term elections regarding his administration’s continued drug pricing reform efforts. Healthcare leadership under the Trump administration unveiled a three-prong plan using the Center for Medicare and Medicaid Innovation (CMMI) to test three ways to lower the costs of drugs, aimed largely at Medicare …
Autumn signals seasonal changes, but one constant is the annual assessment of the policy implications of the proposed Medicare payment rules for the upcoming calendar year. In this 2019 rule-making cycle, access to care and the overall reimbursement and healthcare delivery landscape have the potential to undergo a drastic shift. In September ACCC submitted comments to both the 2019 Physician Fee Schedule …
Nearly four months have passed since the Trump Administration released its blueprint for lowering drug prices. In the intervening time, there has been scrutiny of administration discussion on implementation of various proposals outlined in the plan. Most recently, during the month of August the Centers for Medicare & Medicaid Services (CMS) used its authority to the fullest, releasing two policy …
The University of North Carolina (UNC), North Carolina Cancer Hospital was the first program in the nation to adopt a closed-system transfer device that has saved $39 million in drug expense annually by reducing waste. This 2018 ACCC Innovator Award recipient will describe the process behind drug vial optimization at the ACCC 35th National Oncology Conference in October. In this guest blog post, Lindsey …
In this guest blog post from 2018 ACCC Innovator Award winner Legacy Cancer Institute in Portland, Oregon, Oncology Pharmacy Navigator Kelly Rice, PharmD, shares how her position has evolved and the benefits its bringing for patients and her cancer program. At the Legacy Cancer Institute in Portland, Oregon, the position of Oncology Pharmacy Navigator has become an integral part of our program. During …
On July 25, 2018, the Centers for Medicare & Medicaid Services (CMS) released the CY 2019 Outpatient Prospective Payment System (OPPS) proposed rule, and we are seeing several efforts to continue the push towards “site neutral” payments in off-campus provider-based departments (PBDs). This rule was issued weeks after the CY 2019 Physician Fee Schedule (PFS) proposed rule, and the atypical lag time …
Secretary Alex Azar has expressed strong interest in revitalizing Medicare’s Competitive Acquisition Program (CAP) and introducing negotiation into Part B drug pricing.
Next Tuesday, June 26, HHS Secretary Alex Azar returns to Capitol Hill to testify on the administration’s proposed drug pricing plan. Only a week ago, Azar appeared before the Senate Health, Education, Labor, and Pensions (HELP) Committee on June 12, answering questions on the administration’s blueprint, released in May, that aims to tackle rising drug costs in the United States. Within the …
As oncology engages in value-based reimbursement, new payment models, and precision medicine, oncology pharmacists and pharmacy staff are integral to the successful delivery of quality, cost-effective patient care.
    Displaying results 121 - 140 of 161
  • «
  • ...
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • »